The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and Risks
Abstract
The present study examined reasons for the high incidence of hepatitis C virus (HCV) infection among young injection drug users (IDUs). IDUs <30 years old who tested negative for HCV antibody were enrolled in a prospective cohort. Risk factors for seroconversion were examined using time-dependent regression analyses: 48 of 195 IDUs seroconverted to HCV, for an incidence rate of 25.1/100 person-years (95% confidence interval, 18.7-32.9/100 person-years). Independent risk factors included sharing needles with an HCV-infected sex partner (borderline statistical significance, P=.11) or a person who was not a sex partner, sharing nonsterile drug-preparation equipment, pooling money with another IDU to buy drugs, and exchanging sex for money. Ubiquitous behaviors among young IDUs, such as the forming of injecting or sexual partnerships and consequent sharing of needles and drug preparation equipment, are risk factors for HCV. Interventions to reduce HCV transmission must recognize the importance of relationships on injecting risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sharing of drug preparation equipment as a risk factor for hepatitis C
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.1.42 · Cited by 500
Thorpe, L. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.7.645 · Cited by 444
Bourgois, P. (1998) · Substance Use & Misuse · doi:10.3109/10826089809056260 · Cited by 393
Self-citationPrevalence and Incidence of Hepatitis C Virus Infection Among Young Adult Injection Drug Users
Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E., & Vlahov, D. (1998) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199802001-00004 · Cited by 346
Syringe and Needle Exchange as HIV/AIDS Prevention for Injection Drug Users
Watters, J. K. (1994) · JAMA · doi:10.1001/jama.271.2.115 · Cited by 330
Evans, J. L. (2003) · Journal of Urban Health: Bulletin of the New York Academy of Medicine · doi:10.1093/jurban/jtg137 · Cited by 314
Self-citationSyringe and Needle Exchange as HIV/AIDS Prevention for Injection Drug Users
Watters, J. K. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510260047027 · Cited by 284
van Beek, I., Dwyer, R., Dore, G. J., Luo, K., & Kaldor, J. M. (1998) · BMJ · doi:10.1136/bmj.317.7156.433 · Cited by 234
Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland
Villano, S. A., Vlahov, D., Nelson, K. E., Lyles, C. M., Cohn, S., & Thomas, D. L. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.12.3274-3277.1997 · Cited by 227
Hahn, J. A., Page-Shafer, K., Lum, P. J., Ochoa, K., & Moss, A. R. (2001) · Hepatology · doi:10.1053/jhep.2001.25759 · Cited by 204
Self-citationThe effect of syringe exchange use on high-risk injection drug users: a cohort study
Bluthenthal, R. N., Kral, A. H., Gee, L., Erringer, E. A., & Edlin, B. R. (2000) · AIDS · doi:10.1097/00002030-200003310-00015 · Cited by 199
Jarlais, D. C. D. (1994) · JAMA · doi:10.1001/jama.271.2.121 · Cited by 192
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.1.23 · Cited by 189
Needle sharing in context: patterns of sharing among men and women injectors and HIV risks
BARNARD, M. A. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02094.x · Cited by 179
HIV seroconversion in intravenous drug users in San Francisco, 1985–1990
Moss, A. R., Vranizan, K., Gorter, R., Bacchetti, P., Watters, J., & Osmond, D. (1994) · AIDS · doi:10.1097/00002030-199402000-00010 · Cited by 178
Self-citationvan Ameijden, E. J. C., Van Den Hoek, J. A. R., Mientjes, G. H. C., & Coutinho, R. A. (1993) · European Journal of Epidemiology · doi:10.1007/bf00146260 · Cited by 161
Thorpe, L. E., Ouellet, L. J., Levy, J. R., Williams, I. T., & Monterroso, E. R. (2000) · The Journal of Infectious Diseases · doi:10.1086/317607 · Cited by 160
Koester, S. K. (1994) · Human Organization · doi:10.17730/humo.53.3.g86872408528021h · Cited by 159
Grund, J., Friedman, S. R., Stern, L. S., Jose, B., Neaigus, A., Curtis, R., & Jarlais, D. C. D. (1996) · Social Science & Medicine · doi:10.1016/0277-9536(95)00193-x · Cited by 138
Crofts, N., & Aitken, C. K. (1997) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1997.tb138757.x · Cited by 136
Drug Injecting and HIV Infection
(2003) · Routledge eBooks · doi:10.4324/9780203214015 · Cited by 126
Needle, R. H., Coyle, S. L., Cesari, H., Trotter, R. T., Clatts, M. C., Koester, S. K., Price, L. J., McLellan–Lemal, E., Finlinson, A., Bluthenthal, R. N., et al. (1998) · Substance Use & Misuse · doi:10.3109/10826089809059332 · Cited by 118
Maximum impact of HIV prevention measures targeted at injecting drug users
van Ameijden, E. J. C., & Coutinho, R. A. (1998) · AIDS · doi:10.1097/00002030-199806000-00012 · Cited by 109
Kral, A. H., Lorvick, J., & Edlin, B. R. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200006010-00011 · Cited by 109
Drug Paraphernalia Laws and Injection-Related Infectious Disease Risk among Drug Injectors
Bluthenthal, R. N., Kral, A. H., Erringer, E. A., & Edlin, B. R. (1999) · Journal of Drug Issues · doi:10.1177/002204269902900101 · Cited by 95
Busch, M. P. (2001) · Transfusion Clinique et Biologique · doi:10.1016/s1246-7820(01)00125-2 · Cited by 91
Self-citationThe Prevalence of Additional Injection-Related HIV Risk Behaviors Among Injection Drug Users
Koester, S. K., Booth, R. E., & Zhang, Y. (1996) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199606010-00015 · Cited by 79
Neaigus, A., Friedman, S. R., Goldstein, M., Ildefonso, G., Curtis, R., & Jose, B. (1995) · PsycEXTRA Dataset · doi:10.1037/e495782006-004 · Cited by 78
Theory, Method, and Power in Drug and HIV-Prevention Research: A Participant-Observer's Critique
Bourgois, P. I. (1999) · Substance Use & Misuse · doi:10.3109/10826089909039443 · Cited by 71
Self-citationMcCoy, C. B., Metsch, L. R., Chitwood, D. D., Shapshak, P., & Comerford, S. T. (1998) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199802001-00006 · Cited by 67
Risk and Reciprocity: HIV and the Injection Drug User
Zule, W. A. (1992) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1992.10471644 · Cited by 67
Risk factors for hepatitis C virus infection among injecting drug users in Sydney.
van Beek, I., Buckley, R., Stewart, M., MacDonald, M., & Kaldor, J. M. (1994) · Sexually Transmitted Infections · doi:10.1136/sti.70.5.321 · Cited by 53
Cumulative incidence of hepatitis C seroconversion in a cohort of seronegative injecting drug users.
Brunton, C. R., Kemp, R., Raynel, P. D., Harte, D., & Baker, M. (2000) · PubMed · Cited by 22
Cited by
Hepatitis C virus infection in USA: an estimate of true prevalence
Chak, E., Talal, A. H., Sherman, K. E., Schiff, E. R., & Saab, S. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02494.x · Cited by 396
Woody, G. E., Poole, S. A., Subramaniam, G., Dugosh, K., Bogenschutz, M., Abbott, P., Patkar, A., Publicker, M., McCain, K., Potter, J. S., et al. (2008) · JAMA · doi:10.1001/jama.2008.574 · Cited by 361
The Everyday Violence of Hepatitis C among Young Women Who Inject Drugs in San Francisco
Bourgois, P., Prince, B., & Moss, A. (2004) · Human Organization · doi:10.17730/humo.63.3.h1phxbhrb7m4mlv0 · Cited by 318
Self-citationHagan, H., Pouget, E. R., & Des Jarlais, D. C. (2011) · Journal of Infectious Diseases · doi:10.1093/infdis/jir196 · Cited by 313
Evans, J. L. (2003) · Journal of Urban Health: Bulletin of the New York Academy of Medicine · doi:10.1093/jurban/jtg137 · Cited by 314
Self-citation
Metadata
- Authors
- Hahn, J. A., Page‐Shafer, K., Lum, P. J., Bourgois, P., Stein, E., Evans, J. L., Busch, M. P., Tobler, L. H., Phelps, B., & Moss, A. R.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12
- Volume
- 186
- Issue
- 11
- Pages
- 1558-1564
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2098055114
- Cited by
- 326
- References
- 33
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.